Skip to main content

Month: December 2020

AB Science issues a corrective press release regarding adverse events information from study AB09004 reported on December 16, 2020

PRESS RELEASEAB SCIENCE ISSUES A CORRECTIVE PRESS RELEASEParis, December 17, 2020, 8am CETAB Science SA (Euronext – FR0010557264 – AB) today announced that the press release issued on December 16, 2020 regarding the results from study AB09004, which evaluated masitinib in the treatment of Alzheimer disease, contained a material error in the adverse events information reported.The percentage of adverse events observed in study AB09004 study comparing the efficacy and safety of masitinib relative to placebo after 24 weeks of treatment when administered as an add-on therapy to cholinesterase inhibitor (donepezil, rivastigmine or galantamine) and/or memantine, were the following with masitinib 4.5 mg/kg/day:87.0 % of patients had at least one adverse event in the masitinib arm versus 77.5 % in the control arm13.0 % of patients...

Continue reading

AB Science publie un communiqué de presse correctif concernant les informations sur les effets indésirables de l’étude AB09004 annoncées le 16 décembre 2020

COMMUNIQUE DE PRESSEAB SCIENCE PUBLIE UN COMMUNIQUE DE PRESSE CORRECTIFParis, 17 décembre 2020, 8h00AB Science SA (Euronext – FR0010557264 – AB) a annoncé aujourd’hui que le communiqué de presse publié le 16 décembre 2020 concernant les résultats de l’étude AB09004, qui a évalué le masitinib dans le traitement de la maladie d’Alzheimer, contenait une erreur matérielle dans les informations sur les effets indésirables.Le pourcentage d’effets indésirables observés dans l’étude AB09004 comparant l’efficacité et la tolérance du masitinib par rapport au placebo après 24 semaines de traitement lorsqu’il est administré en complément d’un inhibiteur de cholinestérase (donépézil, rivastigmine ou galantamine) et/ou de la mémantine, était le suivant à la dose de 4.5 mg/kg/jour :87,0 % des patients...

Continue reading

Managers of the INVL Technology portfolio company NRD Cyber Security will get option incentives

The managers of NRD Cyber Security, a cybersecurity company owned by the IT business investment company INVL Technology, will be given the incentive of options to acquire shares of the company. The Investment Committee of INVL Technology agreed that the managers of NRD Cyber Security will be able to acquire up to 10% of the company’s shares and thus participate in the increase of the company’s value.This is the first company to benefit from the type of employee incentive programme approved at the extraordinary general meeting of shareholders of INVL Technology held on 29 October this year. One of the most important objectives is the engagement of key employees in the growth of the company’s value, so it is planned to allocate up to 10% of the growth in the company’s value exceeding the minimum annual return of 15% agreed by the parties,...

Continue reading

„INVL Technology“ portfelio bendrovės „NRD Cyber Security“ vadovai bus motyvuojami opcionais

Investicijų į informacinių technologijų verslus bendrovės „INVL Technology“ valdomos kibernetinio saugumo įmonės „NRD Cyber Security“ vadovai bus motyvuojami akcijų opcionais, suteikiančiais teisę įsigyti šios bendrovės akcijų. „INVL Technology“ investicinis komitetas pritarė, kad „NRD Cyber Security“ vadovai galės įsigyti iki 10 proc. akcijų ir taip dalyvauti įmonės vertės didinime.Tai pirmoji įmonė, kuriai pradedama taikyti tokia darbuotojų motyvavimo programa, patvirtinta š. m. spalio 29 d. vykusiame „INVL Technology“ neeiliniame visuotiniame akcininkų susirinkime. Vienas iš svarbiausių tikslų – svarbių darbuotojų įtraukimas į įmonės vertės augimą, todėl planuojama skirti iki 10 proc. bendrovės vertės prieaugio, viršijančio šalių sutartą minimalią 15 proc. metinę grąžą, skaičiuojant nuo pradinės 6,6 mln. EUR vertės 2019 metų pabaigoje.Atsižvelgiant...

Continue reading

Uxin Reports Unaudited Second Quarter of Fiscal Year 2021 Financial Results

BEIJING, Dec. 17, 2020 (GLOBE NEWSWIRE) — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading nationwide online used car dealer in China, today announced its unaudited financial results for the quarter ended September 30, 2020.Highlights for the Quarter Ended September 30, 20202C transaction volume (completed with the use of online sales) was 2,653 units for the three months ended September 30, 2020, compared with 1,702 units in the prior quarter ended June 30, 2020. 2C transaction volume (completed with the use of offline sales) was 23,566 units in the same period last year.2C GMV1 was RMB293 million for the three months ended September 30, 2020, compared with RMB2,828 million in the same period last year.Total revenues were RMB76.4 million (US$11.2 million) for the three months ended September 30, 2020, compared with...

Continue reading

ATEC Continues to Advance Clinical Prowess with Renewed Agreement to Acquire EOS Imaging

Improves clinical performance in spine by adding unprecedented information to the AlphaInformatiX PlatformAccelerates revenue growth through immediate access to EOS’ prestigious 380-unit installed base, which overlaps minimally with ATEC’s client baseFacilitates future global expansion via EOS’ established infrastructureLeverages the portfolio adoption driven by SafeOp with significant incremental opportunities to monetize clinical informationHosting webcast for investors December 17 at 6:00 A.M. PTCARLSBAD, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that it has entered into an agreement to acquire EOS imaging, SA, for a purchase price of $79.7 million, plus the retirement...

Continue reading

Sequana Medical Announces January 2021 Investor Conference Schedule

GHENT, Belgium, Dec. 17, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces that its management team will participate in two upcoming virtual investor conferences, being held in parallel with the JP Morgan 39th Annual Healthcare Conference.10thAnnual LifeSci Advisors Corporate Access Event, 6-8 and 11-14 January 2021H.C. Wainwright Bioconnect 2021, 11-14 January 2021The company presentation with webcast by Ian Crosbie, CEO, will be available on demand as of 11 January 2021 on the Conference website and on the Sequana Medical Investors website.To request a one-on-one meeting with Sequana Medical management at one of these events, contact us at IR@sequanamedical.com.For more information, please...

Continue reading

EXEL INDUSTRIES :2019-2020 Annual Results Strong cash flow generation despite the health crisis

PRESS RELEASE                                                                                                                                                                                                                                          December 17, 20202019-2020 Annual ResultsStrong cash flow generation despite the health crisis EXEL Industries group CEO Yves Belegaud said: “Within an extremely turbulent context on a general and sanitary stand point, the EXEL Industries group has demonstrated an excellent resilience. Our operational results were slightly higher than last year despite a light decrease of our top line, and the cash flow generation enabled us to cover a significant portion of the iNTEC acquisition cost. Our ability to overcome these periods year after year is underpinned by continuing diversification, which enables...

Continue reading

EXEL INDUSTRIES :Résultats annuels 2019- 2020 Une solide génération de cash-flow, malgré la crise sanitaire

COMMUNIQUE DE PRESSE                                                                              Le 17 décembre 2020Résultats annuels 2019- 2020Une solide génération de cash-flow, malgré la crise sanitaire Yves BELEGAUD, Directeur Général du groupe EXEL Industries a déclaré : « Dans un contexte général et sanitaire extrêmement perturbé, le groupe EXEL Industries affiche une belle résilience.. Nos résultats opérationnels sont en légère hausse malgré une légère baisse de l’activité, et notre génération de cash a permis d’effacer une bonne partie du coût d’acquisition d’iNTEC. Notre capacité à franchir ces périodes se concrétise, année après année, grâce à la poursuite de la diversification qui permet de compenser des cycles d’activité différents. Nous bénéficierons à l’avenir des plans d’amélioration de la performance opérationnelle et...

Continue reading

Klépierre: KLÉPIERRE SIGNS A €1.4BN SUSTAINABILITY-LINKED REVOLVING CREDIT FACILITY

PRESS RELEASEKLÉPIERRE SIGNS A €1.4BN SUSTAINABILITY-LINKED REVOLVING CREDIT FACILITYParis — December 17, 2020Klépierre, the European leader in shopping malls, is today announcing the successful closing of a syndicated revolving credit facility for a total amount of €1,385 million. This five-year facility (incorporating two options to extend the maturity by an additional year each) replaces the former facilities maturing in 2021 and 2022. The Group’s liquidity position now stands at €3.1 billion (€2.3 billion for the RCF, €0.4 billion in cash and €0.4 billion in bank overdrafts), with an average maturity of 4.9 years, fully covering Klépierre’s refinancing needs through March 2024.This sustainability-linked revolving credit facility was also designed to support the Group’s ambition to achieve carbon neutrality for its portfolio by 2030....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.